Bepreve 15 mg/mL
bepotastine besilate · SOLUTION/ DROPS · Bausch & Lomb Incorporated
Bepreve is a prescription eye drop containing bepotastine that is used to relieve itching caused by allergies affecting the eyes. It works by blocking certain immune responses in the eye that trigger allergic symptoms.
Key Facts
- Brand Name
- Bepreve
- Generic Name
- bepotastine besilate
- NDC Code (Product)
24208-629- Manufacturer
- Bausch & Lomb Incorporated
- Strength
- 15 mg/mL
- Dosage Form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Marketing Status
- Application #
- NDA022288
- Marketing Start
- 09/08/2009
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
1 INDICATIONS AND USAGE BEPREVE ® (bepotastine besilate ophthalmic solution) 1.5% is a histamine H 1 receptor antagonist indicated for the treatment of itching associated with signs and symptoms of allergic conjunctivitis. BEPREVE is a histamine H1 receptor antagonist indicated for the treatment of itching associated with allergic conjunctivitis. ( 1 )
Dosage & Administration
2 DOSAGE AND ADMINISTRATION Instill one drop of BEPREVE into the affected eye(s) twice a day. Remove contact lenses prior to instillation of BEPREVE. • Instill one drop into the affected eye(s) twice a day. ( 2 ) • Remove contact lenses prior to instillation of BEPREVE. ( 2 )
Contraindications
4 CONTRAINDICATIONS BEPREVE is contraindicated in patients with a history of hypersensitivity reactions to bepotastine or any of the other ingredients [see Adverse Reactions ( 6.2 )] . Hypersensitivity to any component of this product. ( 4 )
Adverse Reactions
6 ADVERSE REACTIONS The most common adverse reaction occurring in approximately 25% of patients was a mild taste following instillation. Other adverse reactions which occurred in 2-5% of subjects were eye irritation, headache, and nasopharyngitis. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-553-5340 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice. The most common reported adverse reaction occurring in approximately 25% of subjects was a mild taste following instillation. Other adverse reactions occurring in 2-5% of subjects were eye irritation, headache, and nasopharyngitis. 6.2 Post-Marketing Experience Hypersensitivity reactions have been reported rarely during the post-marketing use of BEPREVE. Because these reactions are reported voluntarily from a population of unknown size, it is not always possible to reliably estimate their freq…
Frequently Asked Questions
What is Bepreve used for?
Bepreve is a prescription eye drop containing bepotastine that is used to relieve itching caused by allergies affecting the eyes. It works by blocking certain immune responses in the eye that trigger allergic symptoms.
Is Bepreve a controlled substance?
Bepreve is not classified as a controlled substance by the DEA.
What is the generic name for Bepreve?
The generic name for Bepreve is bepotastine besilate. There are 7 other brand versions of bepotastine besilate.
What is the NDC code for Bepreve 15 mg/mL?
The NDC (National Drug Code) for Bepreve 15 mg/mL is 24208-629, listed by Bausch & Lomb Incorporated.
Other Bepotastine Brands
See all →- Bepotastine Besilate15 mg/mL0378-7055
- Bepotastine Besilate Ophthalmic Solution 1.5%15 mg/mL62332-598
- Bepotastine Besilate15 mg/mL70069-711
- Bepotastine Besilate15 mg/mL70069-712
- Bepotastine Besilate15 mg/mL82260-630
- Bepotastine Besilate15 mg/mL24208-630
- Bepotastine Besilate Ophthalmic Solution 1.5%15 mg/mL46708-598
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)